Description
Description
This page contains brief details about the drug enzalutamide, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Enzalutamide is an anticancer drug that belongs to the category of medicines known as antimetabolite. It was approved by the U.S. FDA on 31st of August 2012 to treat Prostate cancer.
Mechanism of Action of Enzalutamide
It works by inhibiting the active form of testosterone, called dihydrotestosterone. It selectively blocks the androgen receptors and disrupts the translocation of signals from the receptor to the cell. Thus, the androgen hormone does not bind to the androgen receptors and these androgen receptors do not interact with DNA. This blocks the functioning of cancer cells and reduces its multiplication.
Uses of Enzalutamide
Enzalutamide is prescribed to treat metastatic castration-resistant prostate cancer (mCRPC) and metastatic castration-sensitive prostate cancer (mCSPC).
Enzalutamide Dosage available
Enzalutamide is to be administered orally. This medication is to be swallowed as whole with water, without cutting, crushing or chewing. It can be taken with or without food.
